BAYRAK EBT TABAN SANAYI VE TICARET A.S.

As of June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. carries a market capitalization of 1.15B, placing it among publicly traded companies globally. Its enterprise value stands at 1.38B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. has 250.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 4.44, and the price-to-book ratio stands at 4.83.

These figures are as of June 30, 2026. The EV/Sales ratio of 5.59 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 1.38B versus a market cap of 1.15B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. maintains a current ratio of 0.74, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 109.49, indicating elevated leverage, while an interest coverage ratio of -0.19 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. posted a negative return on equity (ROE) of -81.59, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -17.64, reflecting losses generated across the asset base. The company generates approximately 1.31M in revenue per employee across its workforce of 189.25, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.29 indicates how many times BAYRAK EBT TABAN SANAYI VE TICARET A.S. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. recorded an income tax benefit of -39.07M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -163.04M and -123.97M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S.'s stock has declined approximately 64.02% over the past 52 weeks. The 50-day moving average sits at 3.62, while the 200-day moving average is 4.50.

Over the twelve months ended June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. generated 247.45M in revenue and converted that into -123.97M in net income, yielding earnings per share of -0.52. EBITDA reached -17.99M, while operating income came in at -81.25M.

As of June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. holds 22.22M in cash and equivalents against 259.45M in total debt, resulting in a net debt position of 219.74M. Total book value stands at 236.96M, with working capital of -115.46M providing operational flexibility.

BAYRAK EBT TABAN SANAYI VE TICARET A.S. produced -46.32M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -1.89M in capital expenditures, free cash flow totaled -48.21M - equivalent to -0.20 per share.

Over the twelve months ended June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. posted a gross margin of 24.42, reflecting its pricing power and cost economics. The operating margin of -32.83 and net profit margin of -50.10 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -4.39: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -1.28, meaning BAYRAK EBT TABAN SANAYI VE TICARET A.S. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

BAYRAK EBT TABAN SANAYI VE TICARET A.S.'s most recent stock split took place on December 30, 2025 with a 400:1771 split ratio.

As of June 30, 2026, BAYRAK EBT TABAN SANAYI VE TICARET A.S. has an Altman Z-Score of 0.73, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.